Literature DB >> 29651054

Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments.

Matthew C Canver1, Maximilian Haeussler2, Daniel E Bauer3,4,5, Stuart H Orkin3,4,5,6, Neville E Sanjana7, Ophir Shalem8,9, Guo-Cheng Yuan10, Feng Zhang11,12,13,14, Jean-Paul Concordet15, Luca Pinello1,11.   

Abstract

CRISPR (clustered regularly interspaced short palindromic repeats) genome-editing experiments offer enormous potential for the evaluation of genomic loci using arrayed single guide RNAs (sgRNAs) or pooled sgRNA libraries. Numerous computational tools are available to help design sgRNAs with optimal on-target efficiency and minimal off-target potential. In addition, computational tools have been developed to analyze deep-sequencing data resulting from genome-editing experiments. However, these tools are typically developed in isolation and oftentimes are not readily translatable into laboratory-based experiments. Here, we present a protocol that describes in detail both the computational and benchtop implementation of an arrayed and/or pooled CRISPR genome-editing experiment. This protocol provides instructions for sgRNA design with CRISPOR (computational tool for the design, evaluation, and cloning of sgRNA sequences), experimental implementation, and analysis of the resulting high-throughput sequencing data with CRISPResso (computational tool for analysis of genome-editing outcomes from deep-sequencing data). This protocol allows for design and execution of arrayed and pooled CRISPR experiments in 4-5 weeks by non-experts, as well as computational data analysis that can be performed in 1-2 d by both computational and noncomputational biologists alike using web-based and/or command-line versions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29651054      PMCID: PMC6182299          DOI: 10.1038/nprot.2018.005

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  91 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Microhomology-based choice of Cas9 nuclease target sites.

Authors:  Sangsu Bae; Jiyeon Kweon; Heon Seok Kim; Jin-Soo Kim
Journal:  Nat Methods       Date:  2014-07       Impact factor: 28.547

3.  High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells.

Authors:  Yuexin Zhou; Shiyou Zhu; Changzu Cai; Pengfei Yuan; Chunmei Li; Yanyi Huang; Wensheng Wei
Journal:  Nature       Date:  2014-04-09       Impact factor: 49.962

4.  Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi.

Authors:  Benjamin E Housden; Alexander J Valvezan; Colleen Kelley; Richelle Sopko; Yanhui Hu; Charles Roesel; Shuailiang Lin; Michael Buckner; Rong Tao; Bahar Yilmazel; Stephanie E Mohr; Brendan D Manning; Norbert Perrimon
Journal:  Sci Signal       Date:  2015-09-08       Impact factor: 8.192

5.  High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing.

Authors:  David Sims; Ana M Mendes-Pereira; Jessica Frankum; Darren Burgess; Maria-Antonietta Cerone; Cristina Lombardelli; Costas Mitsopoulos; Jarle Hakas; Nirupa Murugaesu; Clare M Isacke; Kerry Fenwick; Ioannis Assiotis; Iwanka Kozarewa; Marketa Zvelebil; Alan Ashworth; Christopher J Lord
Journal:  Genome Biol       Date:  2011-10-21       Impact factor: 13.583

6.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors:  Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal:  Nat Biotechnol       Date:  2013-08-01       Impact factor: 54.908

7.  GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.

Authors:  Shengdar Q Tsai; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; Vishal Thapar; Nicolas Wyvekens; Cyd Khayter; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-12-16       Impact factor: 54.908

8.  Nucleosomes impede Cas9 access to DNA in vivo and in vitro.

Authors:  Max A Horlbeck; Lea B Witkowsky; Benjamin Guglielmi; Joseph M Replogle; Luke A Gilbert; Jacqueline E Villalta; Sharon E Torigoe; Robert Tjian; Jonathan S Weissman
Journal:  Elife       Date:  2016-03-17       Impact factor: 8.140

9.  Cas-Database: web-based genome-wide guide RNA library design for gene knockout screens using CRISPR-Cas9.

Authors:  Jeongbin Park; Jin-Soo Kim; Sangsu Bae
Journal:  Bioinformatics       Date:  2016-02-24       Impact factor: 6.937

10.  CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering.

Authors:  Kornel Labun; Tessa G Montague; James A Gagnon; Summer B Thyme; Eivind Valen
Journal:  Nucleic Acids Res       Date:  2016-05-16       Impact factor: 16.971

View more
  26 in total

Review 1.  Technologies and Computational Analysis Strategies for CRISPR Applications.

Authors:  Kendell Clement; Jonathan Y Hsu; Matthew C Canver; J Keith Joung; Luca Pinello
Journal:  Mol Cell       Date:  2020-07-02       Impact factor: 17.970

2.  In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration.

Authors:  Yuemeng Jia; Lin Li; Yu-Hsuan Lin; Purva Gopal; Shunli Shen; Kejin Zhou; Xueliang Yu; Tripti Sharma; Yu Zhang; Daniel J Siegwart; Joseph M Ready; Hao Zhu
Journal:  Cell Stem Cell       Date:  2022-01-31       Impact factor: 24.633

Review 3.  Tutorial: design and execution of CRISPR in vivo screens.

Authors:  Christian J Braun; Andrés Carbonell Adames; Dieter Saur; Roland Rad
Journal:  Nat Protoc       Date:  2022-07-15       Impact factor: 17.021

Review 4.  Transcriptional enhancers at 40: evolution of a viral DNA element to nuclear architectural structures.

Authors:  Sreejith J Nair; Tom Suter; Susan Wang; Lu Yang; Feng Yang; Michael G Rosenfeld
Journal:  Trends Genet       Date:  2022-07-07       Impact factor: 11.821

5.  Base editor scanning charts the DNMT3A activity landscape.

Authors:  Nicholas Z Lue; Emma M Garcia; Kevin C Ngan; Ceejay Lee; John G Doench; Brian B Liau
Journal:  Nat Chem Biol       Date:  2022-10-20       Impact factor: 16.174

6.  Large CRISPR-Cas-induced deletions in the oxamniquine resistance locus of the human parasite Schistosoma mansoni.

Authors:  Geetha Sankaranarayanan; Avril Coghlan; Patrick Driguez; Magda E Lotkowska; Mandy Sanders; Nancy Holroyd; Alan Tracey; Matthew Berriman; Gabriel Rinaldi
Journal:  Wellcome Open Res       Date:  2021-01-20

7.  Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Authors:  Maurice Labuhn; Kelly Perkins; Sören Matzk; Leila Varghese; Catherine Garnett; Elli Papaemmanuil; Marlen Metzner; Alison Kennedy; Vyacheslav Amstislavskiy; Thomas Risch; Raj Bhayadia; David Samulowski; David Cruz Hernandez; Bilyana Stoilova; Valentina Iotchkova; Udo Oppermann; Carina Scheer; Kenichi Yoshida; Adrian Schwarzer; Jeffrey W Taub; John D Crispino; Mitchell J Weiss; Yasuhide Hayashi; Takashi Taga; Etsuro Ito; Seishi Ogawa; Dirk Reinhardt; Marie-Laure Yaspo; Peter J Campbell; Irene Roberts; Stefan N Constantinescu; Paresh Vyas; Dirk Heckl; Jan-Henning Klusmann
Journal:  Cancer Cell       Date:  2019-07-11       Impact factor: 31.743

8.  Common variants in signaling transcription-factor-binding sites drive phenotypic variability in red blood cell traits.

Authors:  Avik Choudhuri; Eirini Trompouki; Brian J Abraham; Leandro M Colli; Kian Hong Kock; William Mallard; Min-Lee Yang; Divya S Vinjamur; Alireza Ghamari; Audrey Sporrij; Karen Hoi; Barbara Hummel; Sonja Boatman; Victoria Chan; Sierra Tseng; Satish K Nandakumar; Song Yang; Asher Lichtig; Michael Superdock; Seraj N Grimes; Teresa V Bowman; Yi Zhou; Shinichiro Takahashi; Roby Joehanes; Alan B Cantor; Daniel E Bauer; Santhi K Ganesh; John Rinn; Paul S Albert; Martha L Bulyk; Stephen J Chanock; Richard A Young; Leonard I Zon
Journal:  Nat Genet       Date:  2020-11-23       Impact factor: 38.330

Review 9.  Potential new approaches to the management of the Hb Bart's hydrops fetalis syndrome: the most severe form of α-thalassemia.

Authors:  Andrew J King; Douglas R Higgs
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

10.  A KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes.

Authors:  Joe R Harman; Ross Thorne; Max Jamilly; Marta Tapia; Nicholas T Crump; Siobhan Rice; Ryan Beveridge; Edward Morrissey; Marella F T R de Bruijn; Irene Roberts; Anindita Roy; Tudor A Fulga; Thomas A Milne
Journal:  Genome Res       Date:  2021-06-04       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.